Read on Twitter
$SOAN.... I shared this OPINION earlier and felt like I should share publicly. I’m not 100% certain of the following statement and suggest you seriously consider DD before taking as serious a position as I have in this stock. It is personally the largest position in my portfolio
I traded strictly bio-pharma for years prior to venturing into the OTC. Allow me to share my 2c here........for those that expected SOAN to hit $1 the week of the conference, well it doesn’t work like that. SOAN will grind up until....
one day a catalyst occurs that catches the eye of investors like Perceptive Advisors or the like. When that happens, you will see a surge in accumulation and a small surge in price, maybe .15-.20 and then boom- a 13G will be filed. On THAT filing, we will go to $1+ to start.
Certain bio-pharm retail investors and smaller funds wait for one of the big boys to make a move first and then attack. SOAN’s advantage is that it is pursuing a combination therapy of already approved compounds- many Israeli pharm companies follow this route.
They can skip phases 1 and 2 for a fee and jump straight to phase 3. Phase 3 is just an larger efficacy report as the safety profile has already been supported and approved. The combo drugs, unless compatiable, would not have been able to be patented if an adverse interaction....
profile would have been detected. My suggestion would be to maintain a core position that is NOT for sale....I’m not saying don’t trade or take profits, I’m saying own a block that you refuse to sell, because when that pop comes the gap WILL NOT fill... best of luck- trade wisely
